{"id":535107,"date":"2021-09-07T16:08:57","date_gmt":"2021-09-07T20:08:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/"},"modified":"2021-09-07T16:08:57","modified_gmt":"2021-09-07T20:08:57","slug":"alpine-immune-sciences-announces-participation-in-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/","title":{"rendered":"Alpine Immune Sciences Announces Participation in September Investor Conferences"},"content":{"rendered":"

<\/p>\n

Alpine Immune Sciences Announces Participation in September Investor Conferences<\/b><\/p>\n

SEATTLE–(BUSINESS WIRE<\/a>)–
\nAlpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune\/inflammatory diseases, today announced that members of its management team will present at the following investor conferences in September 2021:\n<\/p>\n

H.C. Wainwright 23rd<\/sup> Annual Global Investment Conference
\n
<\/b>Date: Monday, September 13, 2021
\n
Time: Available on demand beginning 7:00 a.m. ET\/4:00 a.m. PT
\n
Event: Company Presentation\n<\/p>\n

Oppenheimer Fall Healthcare Summit
\n
<\/b>Date: Monday, September 20, 2021
\n
Time: 2:55 p.m. ET\/11:55 a.m. PT
\n
Event: Fireside Chat\n<\/p>\n

Cantor Global Healthcare Conference
\n
<\/b>Date: Wednesday, September 29, 2021
\n
Time: 2:00 p.m. ET\/11:00 a.m. PT
\n
Event: Company Presentation\n<\/p>\n

\nWebcasts of the H.C. Wainwright, Oppenheimer, and Cantor presentations will be available online in the investor relations section of the company\u2019s website at https:\/\/ir.alpineimmunesciences.com\/events<\/a>. A replay of the presentations will be available on the company website for 90 days following the webcast.\n<\/p>\n

About Alpine Immune Sciences, Inc. <\/b><\/p>\n

\nAlpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients\u2019 lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com<\/a>. Follow @AlpineImmuneSci<\/a> on Twitter<\/a> and LinkedIn<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210907005744\/en\/<\/a><\/span><\/p>\n

Investor Relations
\n<\/b>
Alex Sharif
\n
Director, Investor Relations and Corporate Development
\n
Alpine Immune Sciences, Inc.
\n
206-788-4545
\n
ir@alpineimmunesciences.com<\/a><\/p>\n

Media Relations
\n<\/b>
Kelli Perkins
\n
Red House
\n
Kelli@redhousecomms.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Washington<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health Oncology<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Alpine Immune Sciences Announces Participation in September Investor Conferences SEATTLE–(BUSINESS WIRE)– Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune\/inflammatory diseases, today announced that members of its management team will present at the following investor conferences in September 2021: H.C. Wainwright 23rd Annual Global Investment Conference Date: Monday, September 13, 2021 Time: Available on demand beginning 7:00 a.m. ET\/4:00 a.m. PT Event: Company Presentation Oppenheimer Fall Healthcare Summit Date: Monday, September 20, 2021 Time: 2:55 p.m. ET\/11:55 a.m. PT Event: Fireside Chat Cantor Global Healthcare Conference Date: Wednesday, September 29, 2021 Time: 2:00 p.m. ET\/11:00 a.m. PT Event: Company Presentation Webcasts of the H.C. Wainwright, Oppenheimer, and Cantor presentations will … <\/p>\n

Continue reading “Alpine Immune Sciences Announces Participation in September Investor Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535107","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAlpine Immune Sciences Announces Participation in September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alpine Immune Sciences Announces Participation in September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Alpine Immune Sciences Announces Participation in September Investor Conferences SEATTLE–(BUSINESS WIRE)– Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune\/inflammatory diseases, today announced that members of its management team will present at the following investor conferences in September 2021: H.C. Wainwright 23rd Annual Global Investment Conference Date: Monday, September 13, 2021 Time: Available on demand beginning 7:00 a.m. ET\/4:00 a.m. PT Event: Company Presentation Oppenheimer Fall Healthcare Summit Date: Monday, September 20, 2021 Time: 2:55 p.m. ET\/11:55 a.m. PT Event: Fireside Chat Cantor Global Healthcare Conference Date: Wednesday, September 29, 2021 Time: 2:00 p.m. ET\/11:00 a.m. PT Event: Company Presentation Webcasts of the H.C. Wainwright, Oppenheimer, and Cantor presentations will … Continue reading "Alpine Immune Sciences Announces Participation in September Investor Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T20:08:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Alpine Immune Sciences Announces Participation in September Investor Conferences\",\"datePublished\":\"2021-09-07T20:08:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/\"},\"wordCount\":311,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/\",\"name\":\"Alpine Immune Sciences Announces Participation in September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-09-07T20:08:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alpine Immune Sciences Announces Participation in September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alpine Immune Sciences Announces Participation in September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Alpine Immune Sciences Announces Participation in September Investor Conferences - Market Newsdesk","og_description":"Alpine Immune Sciences Announces Participation in September Investor Conferences SEATTLE–(BUSINESS WIRE)– Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune\/inflammatory diseases, today announced that members of its management team will present at the following investor conferences in September 2021: H.C. Wainwright 23rd Annual Global Investment Conference Date: Monday, September 13, 2021 Time: Available on demand beginning 7:00 a.m. ET\/4:00 a.m. PT Event: Company Presentation Oppenheimer Fall Healthcare Summit Date: Monday, September 20, 2021 Time: 2:55 p.m. ET\/11:55 a.m. PT Event: Fireside Chat Cantor Global Healthcare Conference Date: Wednesday, September 29, 2021 Time: 2:00 p.m. ET\/11:00 a.m. PT Event: Company Presentation Webcasts of the H.C. Wainwright, Oppenheimer, and Cantor presentations will … Continue reading \"Alpine Immune Sciences Announces Participation in September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T20:08:57+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Alpine Immune Sciences Announces Participation in September Investor Conferences","datePublished":"2021-09-07T20:08:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/"},"wordCount":311,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/","name":"Alpine Immune Sciences Announces Participation in September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-09-07T20:08:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210907005744r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/alpine-immune-sciences-announces-participation-in-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Alpine Immune Sciences Announces Participation in September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535107"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535107\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}